Creating Value by Building and Driving Pharmaceutical and Medtech Commercial Businesses in Asia
Perseid Solutions empowers pharmaceutical, biotech, and medtech companies to turn clinical potential into commercial reality across Asia by building a revenue pipeline that works for them.
Drawing on deep, on-the-ground knowledge of Southeast Asian, Greater China and Korean healthcare markets, we create grounded commercial strategies and then manage the execution of these plans. We identify, engage, screen, pitch to and negotiate agreements with the right local distributors, and manage those relationships on our clients' behalf to keep performance, compliance, and commercial priorities on track.
Whether you are a company entering the region for the first time or looking to expand an existing footprint, we act as the local partner who can unravel the complexity of the Asia region, pairing deep experience, proven hands-on capabilities and industry insight with the relationships needed to get products in the hands of Asian consumers and patients.
Decades of Experience & More than $2 billion of closed deals
The Perseid team brings a unique combination of hands on business development and management experience combined with a deep strategic knowledge of the region earned by working with some of the largest Asian pharmaceutical and medtech distributors and multinational companies.
The team brings to the table experience proven across more than 30 completed licensing and M&A transactions collectively worth more than $2 billion in revenue and transaction value.
Louis Payet
Managing Partner
Louis entered Asia 24 years ago after completing a PhD in medicine and started his career in the medical research space. His early career covered several areas in the life sciences space, including venture capital, investment banking and consulting working with pharmaceutical, medtech and digital health companies.
The core of his career was spent in corporate development and business development roles in the pharma and medtech companies. He has worked for Asia’s largest pharmaceutical distributors (Invida Pharma and Zuellig Pharma) where he built a successful track record licensing pharmaceutical and OTC products for sale in the Asia region in addition to closing several M&A transactions. In both companies he also ran successful alliance management functions, managing commercial partners generating several hundreds of millions of dollars in revenue.
In addition to his distributor experience he has also worked for a medtech and OTC company called Sinclair Pharma, where he created and managing a network of regional distributors in Asia. He streamlined the partner portfolio and brought in new distribution partners in key markets like China. He also expand the companies footprint in the region by setting up Sinclair Korea via the acquisition of a local distributor. Finally he supported the successful trade sale of Sinclair Pharma to Huadong Pharmaceuticals in 2018.
Louis has a strong interest in the digital health space. He led various digital health initiatives at Sinclair Pharma and Zuellig Pharma. He completed a licensing partnership with Twill Health in 2022 covering 10 countries in the Asia region, which was Asia’s first digital therapeutics licensing deal. In addition he co-founded the company Peach Health Asia, which licensed and distributed digital health products across 8 countries in the Southeast Asia region.
Partner
Soah Yee Chow
Soah Yee has a diverse background, having spent 16 years in industries ranging from biomedical research to training and customer engagement.
Soah Yee started her career in life sciences and biomedical research upon completion of her PhD at the Institute of Molecular and Cell Biology. She further applied her scientific expertise when she moved to a scientific consultant role at AP Bioventures, helping to critically assess and evaluate projects in early-stage life sciences companies for potential investors.
Keen to expand her horizons, Soah Yee subsequently joined Meteor Insights as the head of training and customer engagement. Working closely with stakeholders, she co-developed the company’s digital focused omnichannel clinical practice support program targeted at the medical aesthetics market, to help enhance the clinics’ customer engagement channels.
With the progress of technology within the healthcare industry, Soah Yee believes that the digital health space will be a significant driver of improved healthcare access across the region, and is excited to be a part of Peach Health Asia. She is committed to playing a role in shaping the future of healthcare by addressing the needs of stakeholders, empowering patients and building a foundation for health equity